This comprehensive guide provides researchers and drug development professionals with an expert-level overview of ELISA (Enzyme-Linked Immunosorbent Assay) protocols tailored specifically for quantifying inflammatory biomarkers in depression studies.
This article provides a comprehensive guide to deep learning (DL) applications in neuroimaging for researchers and biomedical professionals.
This article provides a comprehensive framework for understanding and addressing analytical bias in neuroimaging processing pipelines, tailored for researchers, scientists, and drug development professionals.
This article provides a detailed technical resource for researchers, scientists, and drug development professionals on the use of Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) for targeted manipulation of...
This article provides a comprehensive comparison of Dynamic Causal Modeling (DCM) frameworks used to test neurotransmitter hypotheses in psychiatric and neurological disorders.
This article provides a comprehensive guide to the significant challenges in Dynamic Causal Modeling (DCM) for fMRI model selection, a critical step for inferring effective brain connectivity.
This article provides a detailed exploration of the Dynamic Causal Modeling for Parametric Empirical Bayes (DCM PEB) framework and its transformative application in social neuroscience and neuropsychiatric drug development.
This article provides a comprehensive technical analysis for researchers and drug development professionals on Deep Brain Stimulation (DBS) targeting of the nucleus accumbens (NAc) via the anterior limb of the...
This article provides a detailed, state-of-the-art guide for researchers and clinicians on measuring evoked potentials (EPs) as biomarkers in Deep Brain Stimulation (DBS).
This article provides a comprehensive analysis of DAT-SPECT imaging as a critical tool for quantifying the integrity of presynaptic dopaminergic terminals in the nigrostriatal pathway.